LYVE-1, the lymphatic system and tumor lymphangiogenesis
Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vess...
Uložené v:
| Vydané v: | Trends in immunology Ročník 22; číslo 6; s. 317 - 321 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
01.06.2001
|
| Predmet: | |
| ISSN: | 1471-4906, 1471-4981 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44
+ leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation. |
|---|---|
| AbstractList | Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44+ leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation. Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44 super(+) leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation. Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44 + leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation. Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44+ leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation.Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with its transmembrane receptor CD44 on inflammatory leukocytes and tumor cells. The recent discovery of a new HA receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), expressed predominantly in lymphatic vessels, highlights another aspect of HA biology: its continuous transit through the lymphatic system and its potential involvement in lymph node homing by CD44+ leukocytes and tumor cells. The functional role of LYVE-1 in lymphatic vessels and its application as a marker to study tumor lymphangiogenesis are important areas of investigation. |
| Author | Clasper, Steven Prevo, Remko Jackson, David G Banerji, Suneale |
| Author_xml | – sequence: 1 givenname: David G surname: Jackson fullname: Jackson, David G email: djackson@enterprise.molbiol.ox.ac.uk – sequence: 2 givenname: Remko surname: Prevo fullname: Prevo, Remko – sequence: 3 givenname: Steven surname: Clasper fullname: Clasper, Steven – sequence: 4 givenname: Suneale surname: Banerji fullname: Banerji, Suneale |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11377291$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtLAzEUhYNUbKv-BGVWouBo7jySGURESn1AwYUiuApp5k4bncnUJBX6753a6qKbukpIvnPu5Zw-6ZjGICFHQC-AArt8hoRDmOSUnVI4o5DHLGQ7pLd-zqDzd6esS_rOvVMKKed8j3QBYs6jHHokG729DkM4D_wUg2pRz6bSaxW4hfNYB9IUgZ_XjV1_mYluJmjQaXdAdktZOTxcn_vk5W74MngIR0_3j4PbUahSiHyIOSZREZdMlnGZZEkUj4skYxmHVCk2zvOx4pLlTEWMQ5y0y6qSoix5i8okjvfJycp2ZpvPOTovau0UVpU02Myd4DTLIKVsKwg84gyytAWP1-B8XGMhZlbX0i7EbyYtcLUClG2cs1gKpX2bSmO8lboSQMWyAfHTgFjGKyiInwbEco90Q_03YIvuZqXDNswvjVY4pdEoLLRF5UXR6K0O1xsOqtJGK1l94OIf-m_hfK6Q |
| CitedBy_id | crossref_primary_10_1016_S0002_9440_10_62570_9 crossref_primary_10_1007_s13402_016_0281_9 crossref_primary_10_1111_j_1600_0463_2004_apm11207_0811_x crossref_primary_10_1002_ijc_22550 crossref_primary_10_1111_j_1365_2559_2008_03169_x crossref_primary_10_1186_s12964_024_01574_1 crossref_primary_10_1111_j_1749_6632_2002_tb04876_x crossref_primary_10_1182_blood_2012_08_450502 crossref_primary_10_1111_j_1447_073X_2006_00142_x crossref_primary_10_1016_j_matbio_2018_03_022 crossref_primary_10_1074_jbc_M702889200 crossref_primary_10_1182_blood_2004_01_0222 crossref_primary_10_1002_dvdy_21693 crossref_primary_10_1016_j_bbcan_2003_07_003 crossref_primary_10_1186_1471_2407_8_81 crossref_primary_10_1016_j_mvr_2006_03_005 crossref_primary_10_1158_0008_5472_CAN_05_0863 crossref_primary_10_1136_jitc_2022_006056 crossref_primary_10_3390_cancers16101907 crossref_primary_10_3390_cells10082061 crossref_primary_10_1016_j_addr_2016_01_020 crossref_primary_10_1073_pnas_242401399 crossref_primary_10_3390_ph17121663 crossref_primary_10_1089_15396850360495718 crossref_primary_10_1038_s41598_017_16456_5 crossref_primary_10_1186_1471_2407_10_131 crossref_primary_10_1111_j_0021_8782_2004_00293_x crossref_primary_10_1016_j_ajpath_2014_09_020 crossref_primary_10_3390_pharmaceutics14040838 crossref_primary_10_1002_jemt_10255 crossref_primary_10_1111_j_1469_7580_2006_00650_x crossref_primary_10_1158_0008_5472_CAN_05_1843 crossref_primary_10_1002_path_1943 crossref_primary_10_1016_j_cyto_2012_07_016 crossref_primary_10_1016_j_oraloncology_2006_07_006 crossref_primary_10_1038_modpathol_3800728 crossref_primary_10_1016_j_biopha_2021_111331 crossref_primary_10_1074_jbc_M306411200 crossref_primary_10_1136_ard_2003_005876 crossref_primary_10_1016_S0002_9440_10_62060_3 crossref_primary_10_1126_science_aba7721 crossref_primary_10_1096_fj_202000289R crossref_primary_10_1038_sj_bjc_6603144 crossref_primary_10_1109_JSTQE_2020_3045834 crossref_primary_10_1016_j_immuni_2007_11_017 crossref_primary_10_1158_0008_5472_CAN_05_0885 crossref_primary_10_1007_s11060_010_0148_2 crossref_primary_10_1084_jem_20021346 crossref_primary_10_3109_10428194_2010_517877 crossref_primary_10_1097_ICO_0b013e31821dd986 crossref_primary_10_1016_j_breast_2006_06_007 crossref_primary_10_3390_ijms20153722 crossref_primary_10_1097_00003226_200304000_00021 crossref_primary_10_1111_j_1365_2559_2005_02193_x crossref_primary_10_1016_j_devcel_2024_12_010 crossref_primary_10_1016_S1097_2765_04_00080_2 crossref_primary_10_2353_ajpath_2007_060447 crossref_primary_10_1038_s41467_019_12568_w crossref_primary_10_1111_jop_12143 crossref_primary_10_1007_s00120_005_0833_5 crossref_primary_10_1007_s00418_006_0226_x crossref_primary_10_1111_j_1464_410X_2006_06403_x crossref_primary_10_1111_j_1582_4934_2009_00834_x crossref_primary_10_1007_BF03256244 crossref_primary_10_1186_1756_9966_31_83 crossref_primary_10_1038_nm1078 crossref_primary_10_1002_lsm_20184 crossref_primary_10_2478_v10042_009_0090_3 crossref_primary_10_1002_dvdy_23827 crossref_primary_10_1038_nrc724 crossref_primary_10_1177_20417314251317542 crossref_primary_10_1172_JCI36077 crossref_primary_10_1007_s00441_010_1098_x crossref_primary_10_1002_ijc_22937 crossref_primary_10_1074_jbc_M011004200 crossref_primary_10_1093_femspd_ftv062 crossref_primary_10_1016_j_prp_2005_08_010 crossref_primary_10_1007_s00120_008_1752_z crossref_primary_10_1016_j_ebiom_2019_09_014 crossref_primary_10_1097_01_ju_0000128860_00639_9c crossref_primary_10_1096_fj_01_0945rev crossref_primary_10_1111_rda_14259 crossref_primary_10_1136_thoraxjnl_2018_213021 crossref_primary_10_1016_j_survophthal_2015_12_004 crossref_primary_10_1039_D4TB02199A crossref_primary_10_1007_s10555_006_8496_2 crossref_primary_10_1101_gad_975002 crossref_primary_10_1111_j_1349_7006_2009_01444_x crossref_primary_10_1111_cas_13755 crossref_primary_10_1074_jbc_M115_708305 crossref_primary_10_1039_D3BM00873H crossref_primary_10_1038_nrc863 crossref_primary_10_1038_labinvest_2013_72 crossref_primary_10_1097_mpa_0b13e31803dd307 crossref_primary_10_1016_j_arcmed_2007_12_005 crossref_primary_10_1016_j_pupt_2005_02_003 crossref_primary_10_1186_1477_7819_5_140 crossref_primary_10_1111_j_1349_7006_2008_00885_x crossref_primary_10_1158_1078_0432_CCR_03_0826 crossref_primary_10_1080_09273940701382317 crossref_primary_10_1111_j_1464_410X_2008_08305_x crossref_primary_10_1089_lrb_2012_0019 crossref_primary_10_1093_carcin_bgq109 crossref_primary_10_4161_sgtp_19110 crossref_primary_10_1016_j_nano_2022_102542 crossref_primary_10_1002_ijc_10283 crossref_primary_10_1134_S1068162022050119 crossref_primary_10_1196_annals_1294_008 crossref_primary_10_1007_s00429_006_0091_3 crossref_primary_10_1126_science_1071420 crossref_primary_10_1016_j_semcancer_2019_07_002 crossref_primary_10_1016_S1470_2045_01_00621_0 crossref_primary_10_1038_sj_onc_1205956 crossref_primary_10_3390_ijms25179742 crossref_primary_10_1080_10520295_2020_1714731 crossref_primary_10_1196_annals_1413_003 crossref_primary_10_3892_mmr_2024_13412 crossref_primary_10_1007_s00441_008_0700_y crossref_primary_10_1016_j_urolonc_2012_08_004 crossref_primary_10_1158_1078_0432_CCR_14_2467 crossref_primary_10_1186_1471_2407_7_7 crossref_primary_10_3390_cancers13246302 crossref_primary_10_1111_j_1749_6632_2002_tb04871_x crossref_primary_10_1080_07357900802087234 crossref_primary_10_1042_CBI20100871 crossref_primary_10_1016_j_isci_2025_112971 crossref_primary_10_3390_ijms241814123 crossref_primary_10_1097_01_ico_0000183485_85636_ff crossref_primary_10_1369_jhc_2008_950840 crossref_primary_10_1002_bies_10173 crossref_primary_10_1074_jbc_RA119_011992 crossref_primary_10_3390_molecules23020444 crossref_primary_10_1016_j_jvs_2018_06_195 crossref_primary_10_1111_j_1600_065X_2009_00803_x crossref_primary_10_3389_fimmu_2023_1235812 crossref_primary_10_1089_lrb_2018_0023 crossref_primary_10_1158_0008_5472_CAN_05_3876 crossref_primary_10_1160_TH03_04_0200 crossref_primary_10_3389_fimmu_2023_1127828 crossref_primary_10_1186_1471_2407_9_362 crossref_primary_10_1007_s13534_015_0180_4 crossref_primary_10_1016_j_semcdb_2014_10_002 crossref_primary_10_1002_dvdy_20179 crossref_primary_10_1016_S1535_6108_02_00051_X crossref_primary_10_1128_MCB_01503_06 crossref_primary_10_1371_journal_pone_0092857 crossref_primary_10_1002_jcp_21494 crossref_primary_10_1002_dvdy_20737 crossref_primary_10_1002_glia_10053 crossref_primary_10_3390_ijms19123818 crossref_primary_10_1016_j_aanat_2018_05_003 crossref_primary_10_1002_eji_200323859 crossref_primary_10_1038_nm720 crossref_primary_10_1074_jbc_M608425200 crossref_primary_10_1152_physrev_00052_2009 crossref_primary_10_1016_j_actbio_2013_12_019 crossref_primary_10_1089_lrb_2007_1006 crossref_primary_10_1136_jcp_2003_014480 crossref_primary_10_1016_j_trsl_2022_08_001 crossref_primary_10_1080_17425255_2021_1931682 crossref_primary_10_1210_er_2006_0027 crossref_primary_10_3760_cma_j_issn_0366_6999_20120993 crossref_primary_10_1089_ten_teb_2015_0231 crossref_primary_10_1080_00313020902756253 crossref_primary_10_1007_s10120_012_0216_8 crossref_primary_10_1111_apm_12068 crossref_primary_10_1089_lrb_2004_2_173 crossref_primary_10_1038_nri1258 crossref_primary_10_1080_10739680590900003 crossref_primary_10_3389_fimmu_2015_00236 crossref_primary_10_1016_j_lfs_2007_02_037 crossref_primary_10_1046_j_1365_2133_2002_05073_x crossref_primary_10_1002_path_1451 crossref_primary_10_1097_MPA_0b013e318068fcba crossref_primary_10_1158_0008_5472_CAN_06_2977 crossref_primary_10_1371_journal_pone_0144376 crossref_primary_10_1111_j_1463_1318_2006_01199_x crossref_primary_10_1016_S0753_3322_05_80047_2 crossref_primary_10_1186_s12935_023_02866_1 crossref_primary_10_1007_s00441_006_0171_y crossref_primary_10_1016_j_devcel_2023_06_006 crossref_primary_10_1186_1471_2407_9_64 crossref_primary_10_1111_j_1349_7006_2009_01436_x crossref_primary_10_1038_s41427_023_00527_3 crossref_primary_10_1002_path_1343 crossref_primary_10_1002_ar_20845 crossref_primary_10_1073_pnas_0403317101 crossref_primary_10_1097_MPA_0b013e3181975b8c crossref_primary_10_1111_ajt_16291 crossref_primary_10_1074_jbc_M109_047647 crossref_primary_10_1016_j_surg_2013_04_016 crossref_primary_10_1177_0022034513485599 crossref_primary_10_1111_j_1365_3164_2004_00354_x crossref_primary_10_1016_j_matbio_2018_02_001 crossref_primary_10_2353_ajpath_2008_071147 crossref_primary_10_1097_01_MP_0000051582_75890_2D crossref_primary_10_3109_01902148_2015_1080321 crossref_primary_10_3390_ani12202812 crossref_primary_10_1016_j_pneumo_2013_01_005 crossref_primary_10_1007_s12274_015_0929_1 crossref_primary_10_14402_jkamprs_2014_36_3_85 crossref_primary_10_1038_s41388_019_0832_4 crossref_primary_10_3892_mco_2017_1356 crossref_primary_10_1007_s12105_022_01474_1 crossref_primary_10_1034_j_1600_065X_2003_00072_x |
| Cites_doi | 10.1126/science.278.5338.672 10.1016/S0002-9440(10)65392-8 10.1016/S0092-8674(00)80151-8 10.1016/S0955-0674(00)00135-6 10.1016/0092-8674(90)90694-A 10.1096/fasebj.7.13.7691670 10.1096/fasebj.6.7.1563592 10.1083/jcb.122.1.257 10.1172/JCI116469 10.1016/S0955-0674(97)80116-0 10.1126/science.276.5317.1423 10.1038/84643 10.1016/S0065-2776(08)60537-4 10.1126/science.2408340 10.1083/jcb.144.4.789 10.1093/emboj/20.4.672 10.1016/0014-5793(96)00576-5 10.1023/A:1018540610858 10.1084/jem.178.2.497 10.1242/dev.122.12.3829 10.1006/dbio.1997.8639 10.1042/bj2560153 10.1172/JCI119054 10.1038/84635 10.1042/bj2640823 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.0.CO;2-G 10.1074/jbc.M011004200 10.4049/jimmunol.159.6.2702 10.1016/S0002-9440(10)65285-6 10.1083/jcb.134.4.1075 10.1074/jbc.273.1.338 10.1111/j.1365-3083.1995.tb03667.x 10.1038/nm0695-558 10.1002/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E 10.1006/prep.1998.0971 |
| ContentType | Journal Article |
| Copyright | 2001 Elsevier Science Ltd |
| Copyright_xml | – notice: 2001 Elsevier Science Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
| DOI | 10.1016/S1471-4906(01)01936-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1471-4981 |
| EndPage | 321 |
| ExternalDocumentID | 11377291 10_1016_S1471_4906_01_01936_6 S1471490601019366 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K --M -DZ .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 2KS 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8FE 8FH 8P~ 9M8 AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABEFU ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGQPQ AGUBO AGYEJ AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BPHCQ BVXVI CJTIS CS3 D0L DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IH2 IHE J1W KOM L7B LK8 LUGTX M41 MO0 MVM N9A O-L O9- O9~ OAUVE OK0 OMK OZT P-8 P-9 PC. PQQKQ PROAC Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSI SSZ T5K WOW X7M XJT XPP Y6R Z5R ZCG ZGI ~G- ~HD 3V. 7RV 7X7 8FI AACTN AAIAV ABYKQ AFCTW AFDAS AFKRA AFKWA AHPSJ AJBFU AJOXV AMFUW AZQEC BBNVY BENPR BHPHI FYUFA GUQSH HCIFZ LCYCR M1P M2O M7P RCE RIG VQA XFK ZA5 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
| ID | FETCH-LOGICAL-c512t-e9e42d3f6af3f48423bd4868715cc6b99bc7a696c267134490cf0eaf7842a433 |
| ISICitedReferencesCount | 296 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000169960300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-4906 |
| IngestDate | Sun Nov 09 14:28:28 EST 2025 Sun Sep 28 07:35:45 EDT 2025 Wed Feb 19 01:28:05 EST 2025 Tue Nov 18 21:19:04 EST 2025 Sat Nov 29 03:31:51 EST 2025 Fri Feb 23 02:15:01 EST 2024 Tue Oct 14 19:24:18 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Hyaluronan Immunology Cancer biology tumour lymphangiogenesis leukocyte migration LYVE-1 CD44 lymphatic |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c512t-e9e42d3f6af3f48423bd4868715cc6b99bc7a696c267134490cf0eaf7842a433 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-3 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
| PMID | 11377291 |
| PQID | 17276185 |
| PQPubID | 23462 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_70881506 proquest_miscellaneous_17276185 pubmed_primary_11377291 crossref_citationtrail_10_1016_S1471_4906_01_01936_6 crossref_primary_10_1016_S1471_4906_01_01936_6 elsevier_sciencedirect_doi_10_1016_S1471_4906_01_01936_6 elsevier_clinicalkey_doi_10_1016_S1471_4906_01_01936_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2001-06-01 |
| PublicationDateYYYYMMDD | 2001-06-01 |
| PublicationDate_xml | – month: 06 year: 2001 text: 2001-06-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Trends in immunology |
| PublicationTitleAlternate | Trends Immunol |
| PublicationYear | 2001 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Lee, Spicer (BIB3) 2000; 12 Mouse LYVE–1 is an endocytic receptor for hyaluronan in lymphatic endothelium. Prevo, R. Lesley (BIB18) 1997; 14 Bajorath (BIB21) 2000; 39 Camp (BIB7) 1993; 178 Partanen (BIB33) 1999; 86 in press Fraser (BIB14) 1988; 256 Stamenkovic (BIB19) 1990; 61 Breiteneder-Geleff (BIB27) 1999; 154 Brissett, Perkins (BIB17) 1996; 388 Jeltsch (BIB32) 1997; 276 Laurent, Fraser (BIB10) 1992; 6 Noble (BIB12) 1996; 91 Pepper (BIB30) 2001; 7 Valtola (BIB34) 1999; 154 Mikecz (BIB5) 1995; 1 De Grendele (BIB8) 1997; 278 Skobe (BIB36) 2001; 7 Clark (BIB9) 1996; 134 Kincade (BIB26) 1997; 9 Banerji (BIB1) 1999; 144 Kohda (BIB16) 1996; 86 Verdrengh (BIB6) 1995; 42 Knudson, Knudson (BIB4) 1993; 7 McKee (BIB11) 1996; 98 West (BIB13) 1985; 228 Peach (BIB22) 1993; 122 Lesley (BIB20) 1994; 54 Fraser, Laurent (BIB15) 1989; 143 Kukk (BIB28) 1996; 122 Oh (BIB31) 1997; 188 Bajorath (BIB23) 1998; 273 Tzaicos (BIB29) 1989; 264 Stacker (BIB37) 2001; 7 Liu, Sy (BIB25) 1997; 159 Banerji (BIB24) 1998; 14 Mandriota (BIB35) 2001; 20 Bajorath (10.1016/S1471-4906(01)01936-6_BIB23) 1998; 273 Verdrengh (10.1016/S1471-4906(01)01936-6_BIB6) 1995; 42 Kincade (10.1016/S1471-4906(01)01936-6_BIB26) 1997; 9 Mikecz (10.1016/S1471-4906(01)01936-6_BIB5) 1995; 1 Laurent (10.1016/S1471-4906(01)01936-6_BIB10) 1992; 6 Lesley (10.1016/S1471-4906(01)01936-6_BIB18) 1997; 14 Camp (10.1016/S1471-4906(01)01936-6_BIB7) 1993; 178 Stamenkovic (10.1016/S1471-4906(01)01936-6_BIB19) 1990; 61 Banerji (10.1016/S1471-4906(01)01936-6_BIB24) 1998; 14 Jeltsch (10.1016/S1471-4906(01)01936-6_BIB32) 1997; 276 Clark (10.1016/S1471-4906(01)01936-6_BIB9) 1996; 134 Fraser (10.1016/S1471-4906(01)01936-6_BIB14) 1988; 256 Lesley (10.1016/S1471-4906(01)01936-6_BIB20) 1994; 54 West (10.1016/S1471-4906(01)01936-6_BIB13) 1985; 228 Oh (10.1016/S1471-4906(01)01936-6_BIB31) 1997; 188 Knudson (10.1016/S1471-4906(01)01936-6_BIB4) 1993; 7 Pepper (10.1016/S1471-4906(01)01936-6_BIB30) 2001; 7 Skobe (10.1016/S1471-4906(01)01936-6_BIB36) 2001; 7 Banerji (10.1016/S1471-4906(01)01936-6_BIB1) 1999; 144 Liu (10.1016/S1471-4906(01)01936-6_BIB25) 1997; 159 10.1016/S1471-4906(01)01936-6_BIB2 Fraser (10.1016/S1471-4906(01)01936-6_BIB15) 1989; 143 Noble (10.1016/S1471-4906(01)01936-6_BIB12) 1996; 91 Kukk (10.1016/S1471-4906(01)01936-6_BIB28) 1996; 122 Tzaicos (10.1016/S1471-4906(01)01936-6_BIB29) 1989; 264 Partanen (10.1016/S1471-4906(01)01936-6_BIB33) 1999; 86 Kohda (10.1016/S1471-4906(01)01936-6_BIB16) 1996; 86 Stacker (10.1016/S1471-4906(01)01936-6_BIB37) 2001; 7 Bajorath (10.1016/S1471-4906(01)01936-6_BIB21) 2000; 39 Breiteneder-Geleff (10.1016/S1471-4906(01)01936-6_BIB27) 1999; 154 Mandriota (10.1016/S1471-4906(01)01936-6_BIB35) 2001; 20 McKee (10.1016/S1471-4906(01)01936-6_BIB11) 1996; 98 Valtola (10.1016/S1471-4906(01)01936-6_BIB34) 1999; 154 Peach (10.1016/S1471-4906(01)01936-6_BIB22) 1993; 122 Brissett (10.1016/S1471-4906(01)01936-6_BIB17) 1996; 388 De Grendele (10.1016/S1471-4906(01)01936-6_BIB8) 1997; 278 Lee (10.1016/S1471-4906(01)01936-6_BIB3) 2000; 12 |
| References_xml | – reference: Prevo, R. – volume: 273 start-page: 338 year: 1998 end-page: 343 ident: BIB23 article-title: Identification of CD44 residues important for hyaluronan binding and delineation of the binding site publication-title: J. Biol. Chem. – volume: 154 start-page: 1381 year: 1999 end-page: 1390 ident: BIB34 article-title: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer publication-title: Am. J. Pathol. – volume: 228 start-page: 1324 year: 1985 end-page: 1346 ident: BIB13 article-title: Angiogenesis induced by degradation products of hyaluronic acid publication-title: Science – volume: 159 start-page: 2702 year: 1997 end-page: 2711 ident: BIB25 article-title: Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain publication-title: J. Immunol. – volume: 7 start-page: 192 year: 2001 end-page: 198 ident: BIB36 article-title: Induction of tumor lymphangiogenesis by vascular endothelial growth factor-C promotes breast cancer metastasis publication-title: Nat. Med. – volume: 6 start-page: 2397 year: 1992 end-page: 2404 ident: BIB10 article-title: Hyaluronan publication-title: FASEB J. – volume: 7 start-page: 186 year: 2001 end-page: 191 ident: BIB37 article-title: Vascular endothelial growth factor-D promotes tumour growth and spread via the lymphatics publication-title: Nat. Med. – volume: 188 start-page: 96 year: 1997 end-page: 109 ident: BIB31 article-title: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane publication-title: Dev. Biol. – volume: 122 start-page: 257 year: 1993 end-page: 264 ident: BIB22 article-title: Identification of hyaluronic acid binding sites in the extracellular domain of CD44 publication-title: J. Cell Biol. – volume: 264 start-page: 823 year: 1989 end-page: 828 ident: BIB29 article-title: Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan publication-title: Biochem. J. – volume: 86 start-page: 2406 year: 1999 end-page: 2412 ident: BIB33 article-title: Lack of lymphatics specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumours publication-title: Cancer – volume: 134 start-page: 1075 year: 1996 end-page: 1087 ident: BIB9 article-title: CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma publication-title: J. Cell Biol. – volume: 122 start-page: 3829 year: 1996 end-page: 3837 ident: BIB28 article-title: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development publication-title: Development – volume: 61 start-page: 1303 year: 1990 end-page: 1313 ident: BIB19 article-title: CD44 is the principal cell surface receptor for hyaluronate publication-title: Cell – volume: 154 start-page: 385 year: 1999 end-page: 394 ident: BIB27 article-title: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium publication-title: Am. J. Pathol. – volume: 178 start-page: 497 year: 1993 end-page: 515 ident: BIB7 article-title: CD44 is necessary for optimal contact allergic responses but is not required for normal leucocyte extravasation publication-title: J. Exp. Med. – volume: 7 start-page: 462 year: 2001 end-page: 468 ident: BIB30 article-title: Lymphangiogenesis and tumor metastasis: myth or reality? publication-title: Clin. Cancer Res. – volume: 144 start-page: 789 year: 1999 end-page: 801 ident: BIB1 article-title: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan publication-title: J. Cell Biol. – volume: 256 start-page: 153 year: 1988 end-page: 158 ident: BIB14 article-title: Uptake and degradation of hyaluronan in lymphatic tissue publication-title: Biochem. J. – volume: 9 start-page: 635 year: 1997 end-page: 642 ident: BIB26 article-title: The importance of cellular environment to function of the CD44 matrix receptor publication-title: Curr. Opin. Cell Biol. – volume: 42 start-page: 353 year: 1995 end-page: 358 ident: BIB6 article-title: Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis publication-title: Scand. J. Immunol. – volume: 1 start-page: 558 year: 1995 end-page: 563 ident: BIB5 article-title: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis publication-title: Nature Med. – volume: 20 start-page: 672 year: 2001 end-page: 682 ident: BIB35 article-title: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis publication-title: EMBO J. – volume: 12 start-page: 581 year: 2000 end-page: 586 ident: BIB3 article-title: Hyaluronan: a multifunctional, megaDalton, stealth molecule publication-title: Curr. Opin. Cell Biol. – volume: 91 start-page: 2368 year: 1996 end-page: 2377 ident: BIB12 article-title: Hyaluronan fragments activate an NF-κB/I-κB α autoregulatory loop in murine macrophages publication-title: J. Clin. Invest. – volume: 7 start-page: 1233 year: 1993 end-page: 1241 ident: BIB4 article-title: Hyaluronan-binding proteins in development, tissue homeostasis and disease publication-title: FASEB J. – volume: 39 start-page: 103 year: 2000 end-page: 111 ident: BIB21 article-title: Molecular organization, structural features and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions publication-title: Proteins – volume: 86 start-page: 767 year: 1996 end-page: 775 ident: BIB16 article-title: Solution structure of the link module: a hyaluronan binding domain involved in extracellular matrix stability and cell migration publication-title: Cell – reference: (in press) – volume: 54 start-page: 271 year: 1994 end-page: 335 ident: BIB20 article-title: CD44 and its interaction with the extracellular matrix publication-title: Adv. Immunol. – volume: 14 start-page: 611 year: 1997 end-page: 622 ident: BIB18 article-title: CD44 in inflammation and metastasis publication-title: Glycoconjugate J. – volume: 278 start-page: 672 year: 1997 end-page: 675 ident: BIB8 article-title: Requirement for CD44 in activated T cell extravasation into an inflammatory site publication-title: Science – volume: 98 start-page: 2403 year: 1996 end-page: 2413 ident: BIB11 article-title: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages publication-title: J. Clin. Invest. – reference: . Mouse LYVE–1 is an endocytic receptor for hyaluronan in lymphatic endothelium. – volume: 143 start-page: 41 year: 1989 end-page: 53 ident: BIB15 article-title: Turnover and metabolism of hyaluronan publication-title: Ciba Found. Symp. – volume: 388 start-page: 211 year: 1996 end-page: 216 ident: BIB17 article-title: The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily publication-title: FEBS Letts. – volume: 276 start-page: 1423 year: 1997 end-page: 1425 ident: BIB32 article-title: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice publication-title: Science – volume: 14 start-page: 371 year: 1998 end-page: 381 ident: BIB24 article-title: Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in publication-title: Protein Expres. Purif. – volume: 278 start-page: 672 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB8 article-title: Requirement for CD44 in activated T cell extravasation into an inflammatory site publication-title: Science doi: 10.1126/science.278.5338.672 – volume: 154 start-page: 1381 year: 1999 ident: 10.1016/S1471-4906(01)01936-6_BIB34 article-title: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)65392-8 – volume: 7 start-page: 462 year: 2001 ident: 10.1016/S1471-4906(01)01936-6_BIB30 article-title: Lymphangiogenesis and tumor metastasis: myth or reality? publication-title: Clin. Cancer Res. – volume: 86 start-page: 767 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB16 article-title: Solution structure of the link module: a hyaluronan binding domain involved in extracellular matrix stability and cell migration publication-title: Cell doi: 10.1016/S0092-8674(00)80151-8 – volume: 12 start-page: 581 year: 2000 ident: 10.1016/S1471-4906(01)01936-6_BIB3 article-title: Hyaluronan: a multifunctional, megaDalton, stealth molecule publication-title: Curr. Opin. Cell Biol. doi: 10.1016/S0955-0674(00)00135-6 – volume: 61 start-page: 1303 year: 1990 ident: 10.1016/S1471-4906(01)01936-6_BIB19 article-title: CD44 is the principal cell surface receptor for hyaluronate publication-title: Cell doi: 10.1016/0092-8674(90)90694-A – volume: 7 start-page: 1233 year: 1993 ident: 10.1016/S1471-4906(01)01936-6_BIB4 article-title: Hyaluronan-binding proteins in development, tissue homeostasis and disease publication-title: FASEB J. doi: 10.1096/fasebj.7.13.7691670 – volume: 6 start-page: 2397 year: 1992 ident: 10.1016/S1471-4906(01)01936-6_BIB10 article-title: Hyaluronan publication-title: FASEB J. doi: 10.1096/fasebj.6.7.1563592 – volume: 122 start-page: 257 year: 1993 ident: 10.1016/S1471-4906(01)01936-6_BIB22 article-title: Identification of hyaluronic acid binding sites in the extracellular domain of CD44 publication-title: J. Cell Biol. doi: 10.1083/jcb.122.1.257 – volume: 91 start-page: 2368 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB12 article-title: Hyaluronan fragments activate an NF-κB/I-κB α autoregulatory loop in murine macrophages publication-title: J. Clin. Invest. doi: 10.1172/JCI116469 – volume: 9 start-page: 635 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB26 article-title: The importance of cellular environment to function of the CD44 matrix receptor publication-title: Curr. Opin. Cell Biol. doi: 10.1016/S0955-0674(97)80116-0 – volume: 276 start-page: 1423 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB32 article-title: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice publication-title: Science doi: 10.1126/science.276.5317.1423 – volume: 7 start-page: 192 year: 2001 ident: 10.1016/S1471-4906(01)01936-6_BIB36 article-title: Induction of tumor lymphangiogenesis by vascular endothelial growth factor-C promotes breast cancer metastasis publication-title: Nat. Med. doi: 10.1038/84643 – volume: 143 start-page: 41 year: 1989 ident: 10.1016/S1471-4906(01)01936-6_BIB15 article-title: Turnover and metabolism of hyaluronan publication-title: Ciba Found. Symp. – volume: 54 start-page: 271 year: 1994 ident: 10.1016/S1471-4906(01)01936-6_BIB20 article-title: CD44 and its interaction with the extracellular matrix publication-title: Adv. Immunol. doi: 10.1016/S0065-2776(08)60537-4 – volume: 228 start-page: 1324 year: 1985 ident: 10.1016/S1471-4906(01)01936-6_BIB13 article-title: Angiogenesis induced by degradation products of hyaluronic acid publication-title: Science doi: 10.1126/science.2408340 – volume: 144 start-page: 789 year: 1999 ident: 10.1016/S1471-4906(01)01936-6_BIB1 article-title: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan publication-title: J. Cell Biol. doi: 10.1083/jcb.144.4.789 – volume: 20 start-page: 672 year: 2001 ident: 10.1016/S1471-4906(01)01936-6_BIB35 article-title: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis publication-title: EMBO J. doi: 10.1093/emboj/20.4.672 – volume: 388 start-page: 211 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB17 article-title: The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily publication-title: FEBS Letts. doi: 10.1016/0014-5793(96)00576-5 – volume: 14 start-page: 611 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB18 article-title: CD44 in inflammation and metastasis publication-title: Glycoconjugate J. doi: 10.1023/A:1018540610858 – volume: 178 start-page: 497 year: 1993 ident: 10.1016/S1471-4906(01)01936-6_BIB7 article-title: CD44 is necessary for optimal contact allergic responses but is not required for normal leucocyte extravasation publication-title: J. Exp. Med. doi: 10.1084/jem.178.2.497 – volume: 122 start-page: 3829 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB28 article-title: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development publication-title: Development doi: 10.1242/dev.122.12.3829 – volume: 188 start-page: 96 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB31 article-title: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane publication-title: Dev. Biol. doi: 10.1006/dbio.1997.8639 – volume: 256 start-page: 153 year: 1988 ident: 10.1016/S1471-4906(01)01936-6_BIB14 article-title: Uptake and degradation of hyaluronan in lymphatic tissue publication-title: Biochem. J. doi: 10.1042/bj2560153 – volume: 98 start-page: 2403 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB11 article-title: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages publication-title: J. Clin. Invest. doi: 10.1172/JCI119054 – volume: 7 start-page: 186 year: 2001 ident: 10.1016/S1471-4906(01)01936-6_BIB37 article-title: Vascular endothelial growth factor-D promotes tumour growth and spread via the lymphatics publication-title: Nat. Med. doi: 10.1038/84635 – volume: 264 start-page: 823 year: 1989 ident: 10.1016/S1471-4906(01)01936-6_BIB29 article-title: Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan publication-title: Biochem. J. doi: 10.1042/bj2640823 – volume: 39 start-page: 103 year: 2000 ident: 10.1016/S1471-4906(01)01936-6_BIB21 article-title: Molecular organization, structural features and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions publication-title: Proteins doi: 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.0.CO;2-G – ident: 10.1016/S1471-4906(01)01936-6_BIB2 doi: 10.1074/jbc.M011004200 – volume: 159 start-page: 2702 year: 1997 ident: 10.1016/S1471-4906(01)01936-6_BIB25 article-title: Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain publication-title: J. Immunol. doi: 10.4049/jimmunol.159.6.2702 – volume: 154 start-page: 385 year: 1999 ident: 10.1016/S1471-4906(01)01936-6_BIB27 article-title: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)65285-6 – volume: 134 start-page: 1075 year: 1996 ident: 10.1016/S1471-4906(01)01936-6_BIB9 article-title: CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma publication-title: J. Cell Biol. doi: 10.1083/jcb.134.4.1075 – volume: 273 start-page: 338 year: 1998 ident: 10.1016/S1471-4906(01)01936-6_BIB23 article-title: Identification of CD44 residues important for hyaluronan binding and delineation of the binding site publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.1.338 – volume: 42 start-page: 353 year: 1995 ident: 10.1016/S1471-4906(01)01936-6_BIB6 article-title: Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis publication-title: Scand. J. Immunol. doi: 10.1111/j.1365-3083.1995.tb03667.x – volume: 1 start-page: 558 year: 1995 ident: 10.1016/S1471-4906(01)01936-6_BIB5 article-title: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis publication-title: Nature Med. doi: 10.1038/nm0695-558 – volume: 86 start-page: 2406 year: 1999 ident: 10.1016/S1471-4906(01)01936-6_BIB33 article-title: Lack of lymphatics specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumours publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19991201)86:11<2406::AID-CNCR31>3.0.CO;2-E – volume: 14 start-page: 371 year: 1998 ident: 10.1016/S1471-4906(01)01936-6_BIB24 article-title: Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli publication-title: Protein Expres. Purif. doi: 10.1006/prep.1998.0971 |
| SSID | ssj0015777 |
| Score | 2.1932108 |
| SecondaryResourceType | review_article |
| Snippet | Previous research into hyaluronan (HA) has focused on the role of this abundant tissue glycosaminoglycan in promoting cell migration through interactions with... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 317 |
| SubjectTerms | Animals Biomarkers CD44 Glycoproteins - physiology Humans Hyaluronan Hyaluronan Receptors - physiology leukocyte migration lymphangiogenesis lymphatic Lymphatic System - physiology Lymphatic Vessel Tumors - blood supply LYVE-1 Neovascularization, Pathologic Protein Conformation tumour Vesicular Transport Proteins |
| Title | LYVE-1, the lymphatic system and tumor lymphangiogenesis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1471490601019366 https://dx.doi.org/10.1016/S1471-4906(01)01936-6 https://www.ncbi.nlm.nih.gov/pubmed/11377291 https://www.proquest.com/docview/17276185 https://www.proquest.com/docview/70881506 |
| Volume | 22 |
| WOSCitedRecordID | wos000169960300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1471-4981 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015777 issn: 1471-4906 databaseCode: AIEXJ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa2LVRcEBQoy6PkwAEkUja248THCi0CVCokVmg5WYnjVIFtsso-1J7464wfeZRq1YLEJVp5x3Himcx8tueB0EuMowRQMPWzPCU-DaT045SHAOQUo4ryhGemaslxdHIST6f8y2Dwq4mFWc-isozPz_n8v7Ia2oDZOnT2L9jd3hQa4DcwHa7AdrjeiPHH37-N_UBPncaUswtgl8nKanM2W4_J1VlVu7_K06I61QqvWPSBaucrW-gIkkub7724fOMS36vPVat1Zbl29rNqzzcAoc9dgS9TRK3bPi1V_aOw3kGlhqyXNiF6zlJ2Z6yJjulckbQyBcPnUz5yqa77bbZMS6OBMe5JWl-dEhvX6SwzsbHUV5S-3X_42g4H0FyXHwCkwwnz_0i0bUy3odWkOsMeELEttINh5QRqcefo43j6qT2ICiNTvLO9dxcE9rYb8NUoeO0G2wRvNi1fDIyZ3EN33frDO7Jycx8NVLmHbtuKpBd7aPez87V4gGIrSG88ECOvFSPPipEHYuQZMfKuiNFDNHk_nrz74Ls6G74EuLf0FVcUZyRnSU5yGgPATjMaM1hKh1KylPNURgnjTGKmI4_hjWU-UkkeAWlCCXmEtsuqVI-RF4aJIjiUJAQ6mbM0BgOiGMm4wgzzbIhoMztCuhz0uhTKTLTOhnpShZ5UMQqEmVTBhuiw7Ta3SViu68CaqRdNhDHYRAESc13HuO3oIKiFljfp-qLhsQAVrc_d4COqVguh1wgMcPFmighsvU71OUT7Vji619QZQTEPnvz7gz1Fd7pP9hnaXtYr9RzdkutlsagP0FY0jQ-c2P8Gy5K_zA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LYVE-1%2C+the+lymphatic+system+and+tumor+lymphangiogenesis&rft.jtitle=Trends+in+immunology&rft.au=Jackson%2C+David+G&rft.au=Prevo%2C+Remko&rft.au=Clasper%2C+Steven&rft.au=Banerji%2C+Suneale&rft.date=2001-06-01&rft.pub=Elsevier+Ltd&rft.issn=1471-4906&rft.eissn=1471-4981&rft.volume=22&rft.issue=6&rft.spage=317&rft.epage=321&rft_id=info:doi/10.1016%2FS1471-4906%2801%2901936-6&rft.externalDocID=S1471490601019366 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-4906&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-4906&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-4906&client=summon |